P
Pfizer Portfolio holdings
AUM
$576M
This Quarter Return
-9.46%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.59B
AUM Growth
–
Cap. Flow
+$2.59B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
98.36%
Holding
23
New
23
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Haleon
HLN
|
$1.88B |
| 2 |
BioNTech
BNTX
|
$417M |
| 3 |
Arvinas
ARVN
|
$66.3M |
| 4 |
Allogene Therapeutics
ALLO
|
$46.9M |
| 5 |
Oric Pharmaceuticals
ORIC
|
$43.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Haleon
HLN
$43.9B
| $1.88B | 72.59% |
+197,228,952
| New | +$1.88B |
|
|
2
BioNTech
BNTX
$24B
| $417M | 16.08% |
+3,658,361
| New | +$417M |
|
|
3
Arvinas
ARVN
$568M
| $66.3M | 2.56% |
+3,457,815
| New | +$66.3M |
|
|
4
Allogene Therapeutics
ALLO
$251M
| $46.9M | 1.81% |
+22,032,040
| New | +$46.9M |
|
|
5
Oric Pharmaceuticals
ORIC
$994M
| $43.4M | 1.67% |
+5,376,344
| New | +$43.4M |
|
6
Tourmaline Bio
TRML
$601M
| $25.8M | 1% |
+1,272,214
| New | +$25.8M |
|
7
Wave Life Sciences
WVE
$1.53B
| $23.2M | 0.89% |
+1,875,000
| New | +$23.2M |
|
8
Biohaven
BHVN
$1.63B
| $18.9M | 0.73% |
+505,645
| New | +$18.9M |
|
9
Akero Therapeutics
AKRO
$3.74B
| $15.7M | 0.6% |
+562,626
| New | +$15.7M |
|
10
Pyxis Oncology
PYXS
$79.4M
| $11M | 0.42% |
+7,032,770
| New | +$11M |
|
11
Cardiff Oncology
CRDF
$140M
| $10.5M | 0.4% |
+2,411,575
| New | +$10.5M |
|
12
Caribou Biosciences
CRBU
$174M
| $7.46M | 0.29% |
+4,690,431
| New | +$7.46M |
|
13
Zura Bio
ZURA
$133M
| $7.43M | 0.29% |
+2,970,022
| New | +$7.43M |
|
14
Celcuity
CELC
$2.17B
| $4.57M | 0.18% |
+349,406
| New | +$4.57M |
|
15
ESSA Pharma
EPIX
$11.4M
| $3M | 0.12% |
+1,675,000
| New | +$3M |
|
16
Zentalis Pharmaceuticals
ZNTL
$122M
| $2.89M | 0.11% |
+953,834
| New | +$2.89M |
|
17
Spero Therapeutics
SPRO
$116M
| $2.43M | 0.09% |
+2,362,348
| New | +$2.43M |
|
18
NextCure
NXTC
$13.5M
| $1.89M | 0.07% |
+1,458,550
| New | +$1.89M |
|
19
AN2 Therapeutics
ANTX
$30.1M
| $987K | 0.04% |
+715,295
| New | +$987K |
|
20
Q32 Bio
QTTB
$20.9M
| $956K | 0.04% |
+277,777
| New | +$956K |
|
21
Bolt Biotherapeutics
BOLT
$9.85M
| $335K | 0.01% |
+626,109
| New | +$335K |
|
22
Ginkgo Bioworks
DNA
$750M
| $28.8K | ﹤0.01% |
+2,928
| New | +$28.8K |
|
23
Senseonics Holdings
SENS
$374M
| $22.7K | ﹤0.01% |
+43,426
| New | +$22.7K |
|